These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 26538439)

  • 1. Mesenchymal stem cells and chronic renal artery stenosis.
    Oliveira-Sales EB; Boim MA
    Am J Physiol Renal Physiol; 2016 Jan; 310(1):F6-9. PubMed ID: 26538439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renovascular hypertension: Effects of mesenchymal stem cells in the contralateral hypertensive kidney in rats.
    Oliveira-Sales EB; Varela VA; Maquigussa E; Borges FT; Shimoura CG; Gomes G; Campos RR; Boim MA
    Clin Exp Hypertens; 2016; 38(7):586-593. PubMed ID: 27649588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture.
    Oliveira-Sales EB; Maquigussa E; Semedo P; Pereira LG; Ferreira VM; Câmara NO; Bergamaschi CT; Campos RR; Boim MA
    PLoS One; 2013; 8(11):e78464. PubMed ID: 24223811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplantation of bone marrow-derived MSCs improves renal function and Na
    Lira R; Oliveira M; Martins M; Silva C; Carvalho S; Stumbo AC; Cortez E; Verdoorn K; Einicker-Lamas M; Thole A; de Carvalho L
    Cell Tissue Res; 2017 Aug; 369(2):287-301. PubMed ID: 28374150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine monocyte chemoattractant protein-1 contributes to renal dysfunction in swine renovascular hypertension.
    Zhu XY; Chade AR; Krier JD; Daghini E; Lavi R; Guglielmotti A; Lerman A; Lerman LO
    J Hypertens; 2009 Oct; 27(10):2063-73. PubMed ID: 19730125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose tissue-derived mesenchymal stem cells improve revascularization outcomes to restore renal function in swine atherosclerotic renal artery stenosis.
    Eirin A; Zhu XY; Krier JD; Tang H; Jordan KL; Grande JP; Lerman A; Textor SC; Lerman LO
    Stem Cells; 2012 May; 30(5):1030-41. PubMed ID: 22290832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intra-renal delivery of mesenchymal stem cells attenuates myocardial injury after reversal of hypertension in porcine renovascular disease.
    Eirin A; Zhu XY; Ferguson CM; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
    Stem Cell Res Ther; 2015 Jan; 6(1):7. PubMed ID: 25599803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.
    Kashyap S; Warner GM; Hartono SP; Boyilla R; Knudsen BE; Zubair AS; Lien K; Nath KA; Textor SC; Lerman LO; Grande JP
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F372-84. PubMed ID: 26661648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal ischemia in humans: can cell therapy repair the kidney in occlusive renovascular disease?
    Saad A; Herrmann SM; Textor SC
    Physiology (Bethesda); 2015 May; 30(3):175-82. PubMed ID: 25933818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease.
    Zhang L; Zhu XY; Zhao Y; Eirin A; Liu L; Ferguson CM; Tang H; Lerman A; Lerman LO
    Basic Res Cardiol; 2020 Jan; 115(2):16. PubMed ID: 31938859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.
    Eirin A; Zhu XY; Puranik AS; Tang H; McGurren KA; van Wijnen AJ; Lerman A; Lerman LO
    Kidney Int; 2017 Jul; 92(1):114-124. PubMed ID: 28242034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal denervation reduces sympathetic overactivation, brain oxidative stress, and renal injury in rats with renovascular hypertension independent of its effects on reducing blood pressure.
    Nishi EE; Lopes NR; Gomes GN; Perry JC; Sato AYS; Naffah-Mazzacoratti MG; Bergamaschi CT; Campos RR
    Hypertens Res; 2019 May; 42(5):628-640. PubMed ID: 30573809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective improvement in renal function preserved remote myocardial microvascular integrity and architecture in experimental renovascular disease.
    Urbieta-Caceres VH; Zhu XY; Jordan KL; Tang H; Textor K; Lerman A; Lerman LO
    Atherosclerosis; 2012 Apr; 221(2):350-8. PubMed ID: 22341593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grand Rounds at the British Hypertension Society: renal artery stenosis.
    Brady AJ; Mackenzie IS; Ritchie S; Brown MJ
    J Hum Hypertens; 2007 Sep; 21(9):750-5. PubMed ID: 17625589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension.
    Eirin A; Zhu XY; Ebrahimi B; Krier JD; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
    Cell Transplant; 2015; 24(10):2041-53. PubMed ID: 25420012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of mesenchymal stem cells in renovascular hypertension.
    Oliveira-Sales EB; Varela VA; Bergamaschi CT; Campos RR; Boim MA
    Exp Physiol; 2015 Apr; 100(5):491-5. PubMed ID: 25605443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of surgery for renovascular occlusive disease.
    Stanley JC
    Cardiovasc Surg; 1994 Apr; 2(2):195-202. PubMed ID: 8049946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of renovascular hypertension.
    Textor SC
    Urol Clin North Am; 1984 Aug; 11(3):373-81. PubMed ID: 6380077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative stress contributes to renovascular hypertension.
    Oliveira-Sales EB; Dugaich AP; Carillo BA; Abreu NP; Boim MA; Martins PJ; D'Almeida V; Dolnikoff MS; Bergamaschi CT; Campos RR
    Am J Hypertens; 2008 Jan; 21(1):98-104. PubMed ID: 18091751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with Mesenchymal Stem Cells Improves Renovascular Hypertension and Preserves the Ability of the Contralateral Kidney to Excrete Sodium.
    Varela VA; Oliveira-Sales EB; Maquigussa E; Borges FT; Gattai PP; Novaes ADS; Shimoura CG; Campos RR; Boim MA
    Kidney Blood Press Res; 2019; 44(6):1404-1415. PubMed ID: 31671420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.